Diagonal Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Diagonal Therapeutics's estimated annual revenue is currently $16.4M per year.
- Diagonal Therapeutics's estimated revenue per employee is $497,879
- Diagonal Therapeutics's total funding is $128M.
Employee Data
- Diagonal Therapeutics has 33 Employees.
- Diagonal Therapeutics grew their employee count by 313% last year.
Diagonal Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | President and CEO | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Chief Development Officer (CDO) | Reveal Email/Phone |
4 | SVP, Finance & Corporate Development | Reveal Email/Phone |
5 | VP, Product Development & Leadership | Reveal Email/Phone |
6 | Associate Director Biology | Reveal Email/Phone |
7 | Senior Director, Informatics | Reveal Email/Phone |
8 | Operations Manager | Reveal Email/Phone |
9 | Laboratory and Facility Manager | Reveal Email/Phone |
10 | Senior Scientist | Reveal Email/Phone |
Diagonal Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Diagonal Therapeutics?
Diagonal Therapeutics is a biotech company pioneering a new approach to discovering and developing agonist antibodies. The Company's DIAGONAL platform combines proprietary computational and experimental techniques to overcome historical challenges associated with agonist antibody drug discovery. Diagonal's emerging pipeline – discovered using the DIAGONAL platform – has the potential to deliver life-changing therapies to patients including therapies for hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension. For more information, please visit www.diagonaltx.com.\n \n\n \n \n Show more\n \n\n \n\n\n \n \n Show less
keywords:N/A$128M
Total Funding
33
Number of Employees
$16.4M
Revenue (est)
313%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.1M | 33 | 6% | N/A |
#2 | $7.1M | 33 | 3% | N/A |
#3 | $6.4M | 34 | 62% | $18M |
#4 | $4.8M | 34 | 0% | N/A |
#5 | $6.7M | 34 | 10% | N/A |